Hemab Therapeutics Holdings, Inc.
COAG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002114044
No open-market purchases or sales by Hemab Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; Soros Fund Management is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Hemab Therapeutics Holdings, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- +56 vs. Q1 2026
- Shares held
- 36.3M
- +36.3M vs. Q1 2026
- Total value
- $1.33B
- +$1.33B vs. Q1 2026
- New holders
- 56
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COAG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $1.33B |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Hemab Therapeutics Holdings, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1 | $37 | 0.00% | +1 | New |
| Jones Financial Companies LLLP | 3 | $97 | 0.00% | +3 | New |
| Royal Bank of Canada | 248 | $9.00K | 0.00% | +248 | New |
| Barclays PLC | 1,011 | $37.1K | 0.00% | +1,011 | New |
| Citigroup Inc | 2,095 | $76.9K | 0.00% | +2,095 | New |
| China Universal Asset Management Co., Ltd. | 3,600 | $132.2K | 0.01% | +3,600 | New |
| Morgan Stanley | 4,078 | $149.8K | 0.00% | +4,078 | New |
| Two Sigma Investments, LP | 5,680 | $208.6K | 0.00% | +5,680 | New |
| Squarepoint Ops LLC | 6,252 | $229.6K | 0.00% | +6,252 | New |
| Vanguard Global Advisers, LLC | 7,616 | $279.7K | 0.00% | +7,616 | New |
| Vanguard Portfolio Management LLC | 8,169 | $300.0K | 0.00% | +8,169 | New |
| Weiss Asset Management LP | 10,000 | $367.3K | 0.00% | +10,000 | New |
| Schonfeld Strategic Advisors LLC | 10,813 | $397.2K | 0.00% | +10,813 | New |
| Hudson Bay Capital Management LP | 12,202 | $448.2K | 0.00% | +12,202 | New |
| Landscape Capital Management, L.L.C. | 13,183 | $484.2K | 0.03% | +13,183 | New |
| XTX Topco Ltd | 17,389 | $638.7K | 0.01% | +17,389 | New |
| Gsa Capital Partners LLP | 17,661 | $649.0K | 0.04% | +17,661 | New |
| Manufacturers Life Insurance Company, The | 18,720 | $687.6K | 0.00% | +18,720 | New |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 25,000 | $918.3K | 0.01% | +25,000 | New |
| Seven Grand Managers, LLC | 30,000 | $1.10M | 0.04% | +30,000 | New |
| TD Asset Management Inc | 33,098 | $1.22M | 0.00% | +33,098 | New |
| Ghisallo Capital Management LLC | 40,000 | $1.47M | 0.03% | +40,000 | New |
| Northern Trust Corp | 40,487 | $1.49M | 0.00% | +40,487 | New |
| Parkman Healthcare Partners LLC | 45,000 | $1.65M | 0.17% | +45,000 | New |
| UBS Group AG | 47,351 | $1.74M | 0.00% | +47,351 | New |
| Opaleye Management Inc. | 47,652 | $1.75M | 0.16% | +47,652 | New |
| Standard Life Aberdeen plc | 52,117 | $1.91M | 0.00% | +52,117 | New |
| Burkehill Global Management, LP | 75,000 | $2.75M | 0.10% | +75,000 | New |
| State Street Corp | 76,900 | $2.82M | 0.00% | +76,900 | New |
| Ameriprise Financial Inc | 81,928 | $3.01M | 0.00% | +81,928 | New |
| Charles Schwab Investment Management Inc | 108,236 | $3.98M | 0.00% | +108,236 | New |
| Vanguard Fiduciary Trust Co | 112,499 | $4.13M | 0.00% | +112,499 | New |
| Ensign Peak Advisors, Inc | 115,394 | $4.24M | 0.01% | +115,394 | New |
| Affinity Asset Advisors, LLC | 138,030 | $5.07M | 0.25% | +138,030 | New |
| Woodline Partners LP | 150,040 | $5.51M | 0.02% | +150,040 | New |
| Marshall Wace, LLP | 154,674 | $5.68M | 0.00% | +154,674 | New |
| Braidwell LP | 160,000 | $5.88M | 0.22% | +160,000 | New |
| Geode Capital Management, LLC | 211,798 | $7.78M | 0.00% | +211,798 | New |
| ExodusPoint Capital Management, LP | 218,287 | $8.02M | 0.07% | +218,287 | New |
| Deerfield Management Company, L.P. (Series C) | 275,000 | $10.1M | 0.11% | +275,000 | New |
| BlackRock, Inc. | 283,833 | $10.4M | 0.00% | +283,833 | New |
| Citadel Advisors LLC | 523,450 | $19.2M | 0.01% | +523,450 | New |
| Bellevue Group AG | 550,000 | $20.2M | 0.43% | +550,000 | New |
| Rock Springs Capital Management LP | 575,432 | $21.1M | 1.03% | +575,432 | New |
| Driehaus Capital Management LLC | 715,791 | $26.3M | 0.15% | +715,791 | New |
| Price T Rowe Associates Inc | 746,040 | $27.4M | 0.00% | +746,040 | New |
| Vanguard Capital Management LLC | 780,758 | $28.7M | 0.00% | +780,758 | New |
| JPMorgan Chase & Co | 1,152,420 | $42.3M | 0.00% | +1,152,420 | New |
| Bain Capital Life Sciences Investors, LLC | 1,650,000 | $60.6M | 3.60% | +1,650,000 | New |
| Avoro Capital Advisors LLC | 1,925,150 | $70.7M | 0.63% | +1,925,150 | New |
| Siren, L.L.C. | 2,086,834 | $76.6M | 1.56% | +2,086,834 | New |
| Deep Track Capital, LP | 3,602,093 | $132.3M | 1.95% | +3,602,093 | New |
| Capital International Investors | 3,603,876 | $132.4M | 0.03% | +3,603,876 | New |
| FMR LLC | 3,697,837 | $135.8M | 0.01% | +3,697,837 | New |
| Novo Holdings A/S | 4,180,550 | $153.6M | 8.95% | +4,180,550 | New |
| Ra Capital Management, L.P. | 7,808,627 | $286.8M | 2.49% | +7,808,627 | New |